CareMetx Announces Addition of Nasir Ali as Chief Product Officer

BETHESDA, MD, September 20, 2022 – CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to specialty medications, has  announced the appointment of Nasir Ali as the Company’s Chief Product Officer. Ali is a growth-oriented product and solution management executive with a track record of providing strategic and tactical leadership across the […]

Read More…

CareMetx Announces Addition of Rita Kale to Board of Directors

Kale brings more than 20 years’ experience in healthcare and financial leadership. BETHESDA, MD, July 26, 2022 – CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to specialty medications, today announced that Rita Kale has joined the company’s board of directors. Kale brings over two decades of global healthcare industry experience, with […]

Read More…

CareMetx Announces Executive Leadership Updates to Accelerate Next Phase of Growth

Jim Rowe joins as President and CEO, bringing more than 20 years of experience in healthcare technology Mark Hansan, Co-founder, to assume Executive Chairman role Bethesda, Maryland, June 14, 2022 – CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, today announced executive leadership updates as the senior […]

Read More…

CareMetx Partners with Emerging Therapy Solutions (ETS) to Address High Cost of Therapy for Rare Genetic Diseases

CareMetx’s subsidiary OutcomeRx Insurance Management Services,LLC will leverage access to the Emerging Therapy Solutions (ETS) nationwide network of over 120 medical centers, in order to bolster their Patient Access to Costly and Curative Therapies (PACCT) product, one designed to help payers manage the sudden, high costs of therapies for rare genetic diseases. Bethesda, MD, Nov. […]

Read More…

Veradigm Partners with CareMetx, LLC to Optimize End-to-End Specialty Medication Access and Services Streamlining Patient Care

New Strategic Partnership Will Simplify and Accelerate Specialty Approval Medication Process CHICAGO – OCTOBER 5, 2021 — Veradigm®, a leading provider of healthcare data and technology solutions a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new […]

Read More…

CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company

CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company The acquisition of Phyz Healthcare Solutions offers clients exposure to an expanded network of providers by embedding access to specialty therapies directly into the prescriber workflow. CareMetx, a leading technology-enabled hub services company […]

Read More…

CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership

CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership  Significant investment from General Atlantic and The Vistria Group positions CareMetx for continued growth in supporting patient access to innovative therapies Bethesda, MD, New York, NY and Chicago, IL – January 14, 2021 […]

Read More…

OutcomeRx, a division of CareMetx, LLC announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies

Launch of new reinsurance product will help payers manage sudden, high costs of therapies for rare genetic diseases with goal of reducing access and affordability challenges for patients Bethesda, MD (October 28, 2020) – OutcomeRx (ORx), a division of CareMetx, LLC, announced today a new reinsurance product to provide coverage access to high-cost specialty drugs […]

Read More…